Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model. [electronic resource]
Producer: 20140804Description: 2817-26 p. digitalISSN:- 1538-8514
- Animals
- Antineoplastic Agents -- administration & dosage
- Cell Line, Tumor
- Cell Movement -- drug effects
- Crizotinib
- Disease Models, Animal
- Gene Expression
- Gene Knockdown Techniques
- Hepatocyte Growth Factor -- biosynthesis
- Humans
- Male
- Melanoma -- drug therapy
- Mice
- Neoplasm Metastasis
- Protein Kinase Inhibitors -- administration & dosage
- Proto-Oncogene Proteins c-met -- antagonists & inhibitors
- Pyrazoles -- administration & dosage
- Pyridines -- administration & dosage
- RNA, Small Interfering -- genetics
- Tumor Burden -- drug effects
- Uveal Neoplasms -- drug therapy
- Xenograft Model Antitumor Assays
- Uveal Melanoma
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.